Literature DB >> 33380207

Next-generation sequencing not superior to culture in periprosthetic joint infection diagnosis.

Beau J Kildow1, Sean P Ryan1, Richard Danilkowicz1, Alexander L Lazarides1, Colin Penrose1, Michael P Bolognesi1, William Jiranek1, Thorsten M Seyler1.   

Abstract

AIMS: Use of molecular sequencing methods in periprosthetic joint infection (PJI) diagnosis and organism identification have gained popularity. Next-generation sequencing (NGS) is a potentially powerful tool that is now commercially available. The purpose of this study was to compare the diagnostic accuracy of NGS, polymerase chain reaction (PCR), conventional culture, the Musculoskeletal Infection Society (MSIS) criteria, and the recently proposed criteria by Parvizi et al in the diagnosis of PJI.
METHODS: In this retrospective study, aspirates or tissue samples were collected in 30 revision and 86 primary arthroplasties for routine diagnostic investigation for PJI and sent to the laboratory for NGS and PCR. Concordance along with statistical differences between diagnostic studies were calculated.
RESULTS: Using the MSIS criteria to diagnose PJI as the reference standard, the sensitivity and specificity of NGS were 60.9% and 89.9%, respectively, while culture resulted in sensitivity of 76.9% and specificity of 95.3%. PCR had a low sensitivity of 18.4%. There was no significant difference based on sample collection method (tissue swab or synovial fluid) (p = 0.760). There were 11 samples that were culture-positive and NGS-negative, of which eight met MSIS criteria for diagnosing infection.
CONCLUSION: In our series, NGS did not provide superior sensitivity or specificity results compared to culture. PCR has little utility as a standalone test for PJI diagnosis with a sensitivity of only 18.4%. Currently, several laboratory tests for PJI diagnosis should be obtained along with the overall clinical picture to help guide decision-making for PJI treatment. Cite this article: Bone Joint J 2021;103-B(1):26-31.

Entities:  

Keywords:  Molecular technology arthroplasty; Next generation sequencing; Periprosthetic joint infection; Polymerase chain reaction

Year:  2021        PMID: 33380207     DOI: 10.1302/0301-620X.103B1.BJJ-2020-0017.R3

Source DB:  PubMed          Journal:  Bone Joint J        ISSN: 2049-4394            Impact factor:   5.082


  5 in total

1.  CORR Insights®: What Is the Impact of Automated Synovial Cell Counting on Different Aseptic Causes and Periprosthetic Conditions Associated With Revision THA?

Authors:  Adam J Schwartz
Journal:  Clin Orthop Relat Res       Date:  2021-12-07       Impact factor: 4.176

Review 2.  Diagnostic Value of Next-Generation Sequencing in Periprosthetic Joint Infection: A Systematic Review.

Authors:  Yuchen Tang; Dacheng Zhao; Shenghong Wang; Qiong Yi; Yayi Xia; Bin Geng
Journal:  Orthop Surg       Date:  2021-12-21       Impact factor: 2.071

Review 3.  Diagnosing Periprosthetic Joint Infection: a Scoping Review.

Authors:  Aaron Gazendam; Thomas J Wood; Daniel Tushinski; Kamal Bali
Journal:  Curr Rev Musculoskelet Med       Date:  2022-04-04

4.  Recurrent Failures After 2-Stage Exchanges are Secondary to New Organisms Not Previously Covered by Antibiotics.

Authors:  Fortune J Egbulefu; JaeWon Yang; John C Segreti; Scott M Sporer; Antonia F Chen; Matthew S Austin; Craig J Della Valle
Journal:  Arthroplast Today       Date:  2022-08-27

Review 5.  Molecular Approach for the Laboratory Diagnosis of Periprosthetic Joint Infections.

Authors:  Giulia Gatti; Francesca Taddei; Martina Brandolini; Andrea Mancini; Agnese Denicolò; Francesco Congestrì; Martina Manera; Valentina Arfilli; Arianna Battisti; Silvia Zannoli; Maria Michela Marino; Anna Marzucco; Manuela Morotti; Laura Grumiro; Agata Scalcione; Giorgio Dirani; Monica Cricca; Vittorio Sambri
Journal:  Microorganisms       Date:  2022-08-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.